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Patients with untreated Hodgkin's Disease (HD) often show
T-cell dysfunction irrespective of the stage and grade of the
disease. Our earlier studies have shown defective mitogen
induced blastogenic responses of PHA activated peripheral
blood mononuclear cells (PBMNC - blood lymphocytes)
from untreated HD patients (Moghe et al., 1980) and their
reduced ability to form T-cell colonies in capillaries in soft
agar (Mukhopadhyaya et al., 1983).
An interesting aspect of T-cell immunoregulation in HD,
is the possibility of abnormal distribution of immunoreactive
and immunoregulatory cells in the lymphoid compartments
(DeSouza et al., 1977). In this respect, we and others have
earlier investigated the subsets of T-cells in involved and
uninvolved splenic mononuclear cells (SMNC - spleen
lymphocytes) of HD patients, as assessed by the expression
of receptors for IgG (Ty) and IgM (Tj) or reactivity to
monoclonal antibodies. The results indicated that, in
untreated HD, while blood lymphocytes showed increased
suppressor cells and decreased helper cells, the spleen
lymphocytes showed a higher proportion of helper cells
sequestered in this tissue (Gupta et al., 1980; Herrman et al.,
1983; Gulwani et al., 1985). Enriched Ty populations from
blood and spleen lymphocytes exerted suppressor effects on
responding T-cells in vitro (Gulwani et al., 1986).
It is now well established that availability of interleukin-2
(IL-2) and expression of IL-2 receptors (IL-2R) by activated
T-lymphocytes determine their degree of proliferation (Robb,
1984). We have shown that T-cells from blood lymphocytes
of untreated HD patients responded well to PHA in the
presence of exogenous IL-2. However, there was no improve-
ment in their colony forming ability (Mukhopadhyaya
et al., 1987). The activation of peripheral blood T-
lymphocytes by IL-2 in treated disease-free HD patients has
been investigated by Mantovani et al. (1987). However, there
are hardly any reports which compare the IL-2 mediated
regulation of T-cell activation in blood and spleen
lymphocytes. Such studies might help toward a better
understanding of T-cell hyporesponsiveness and support the
possibility of the existence of ecotaxis in this disease.
In this report we have compared the reactivity of spleen
and blood lymphocytes from untreated HD patients using
the following parameters: (i) blastogenic and colony forming
potential of PHA activated T-cells; (ii) their responses to
exogenous IL-2; and (iii) their ability to generate IL-2 and
express IL-2R.
Splenic lymphocytes were collected from 5 patients. Two
patients had uninvolved spleens who were in the IB (LP) and
IIIA (NS) stages of the disease. Spleen lymphocytes were
obtained from uninvolved portions of the tissue from 3
patients having splenic involvement, their stages of disease
being IIIB (LP), IIIA (LP) and IA (LP). Spleen and blood
lymphocytes were obtained by Ficoll-Hypaque density
gradient separation. The cells were washed 3 times in physio-
logical saline and suspended in RPMI 1640 (Gibco, USA)
with 25mM HEPES buffer and 4mM glutamine,
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supplemented with 10% human AB group serum (for blasto-
genesis and generation of IL-2) or FCS (Gibco, USA, for
colony assay and assessment of IL-2 production). PHA
(Difco, USA) was used as a mitogen at the dose of
10ygml-1. As a source of IL-2, 48h culture supernatants of
multiple MLC (IL-2 CM), set up using blood lymphocytes
from 4-6 normal donors, further activated by a 2h pulse of
PHA were used. The supernatants were depleted of residual
PHA contamination by absorption with chicken RBC.
The methods for blastogenesis and colony formation have
been described previously (Moghe et al., 1980;
Mukhopadhyaya et al., 1983). IL-2 production was studied
by assessing the ability of supernatants of 24h lymphocyte
cultures stimulated with PHA to support the proliferation of
a murine IL-2 dependent T-cell line-CTLL. IL-2R bearing
cells were assessed by indirect immunofluorescence using
'anti-Tac' monoclonal antibody (Uchiyama et al., 1981). Tac
positive cells were scored in resting (unstimulated), PHA
stimulated and mixed lymphocyte cultures.
Both blastogenesis and T-cell colony formation were
significantly depressed in HD blood lymphocytes (Table I) as
has been previously reported on a larger group of subjects
(Moghe et al., 1980; Mukhopadhyaya et al., 1983). However,
both blastogenesis and colony formation by spleen
lymphocytes were comparable to those shown by blood
lymphocytes from normal healthy donors and lymphocytes
from 2 normal spleens obtained from accident cases.
It can also be noted from the table that IL-2 production
by HD blood lymphocytes, as indicated by the 3HTdR
incorporation in CTLL, was significantly less than control
blood lymphocytes. However, although spleen lymphocytes
in general, produced lower amounts of IL-2, HD and control
spleen lymphocytes were able to generate equivalent levels of
IL-2 activity after stimulation with PHA for 24h. There
were hardly any IL-2R bearing cells in the fresh resting
lymphocytes in blood of both healthy donors (0.5+0.4) or
HD patients (1.1 +0.5). PHA stimulated HD blood
lymphocytes showed lower numbers of Tac positive cells
than normal blood lymphocytes, with marginal significance
(P<0.05), while after MLC stimulation, both groups showed
almost identical numbers of Tac antigen bearing cells. High
numbers of Tac antigen positive cells were found in the
resting splenic lymphocyte populations both in HD
(12.2+7.4) and healthy donors (9.5+1.4). This could reflect
the preactivated state of splenic lymphocytes, including B-
cells which are also known to express Tac antigen. As stated
earlier, 3 out of the 5 spleen samples tested by us had splenic
involvement. More Tac positive cells in the resting
population were noted in the uninvolved portions of the
spleen samples. After stimulation with PHA and in MLC,
both HD and control spleen lymphocytes showed
comparable numbers of Tac positive cells.
Figure 1 shows the effect of addition of exogenous IL-2
on blastogenesis and colony formation. We reported earlier
that blood lymphocytes of normal healthy donors showed a
24.8% increase in 3HTdR incorporation on supplementation
with exogenous IL-2, while, the HD blood lymphocytes
showed a marked increase - to the extent of 84.4%
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Table I Functional parameters of activated blood and spleen lymphocytes from normal healthy
donors and HD patients
% Tac + ve cells
~~~~No. of IL-stimulated
with
No. of IL-f
Cell source Blastogenesisf coloniesb productionc PHA MLC
Blood
Healthy donors
(n= 10) 35.42+3.4 585+31 12.27+1.1 52.6+4.7 19.2+1.9
HD (n= 10) 11.86+2.6 218+34 3.17+0.06 38.7+3.0 17.2+1.8
(P<0.001)d (P<0.001) (P<0.001) (P<0.05)
Spleen
Healthy donors
(n=2) 42.69+ 1.6 714+66 6.09+0.3 64.5 24.0
41.03+1.6 1086+120 5.92+0.5 66.0 29.5
HD (n=5) 30.36+4.3 763+49 6.01+0.08 66+13.6 18.3+3.6
aNet cpm+s.e. (x 103); bColonies/106 cells, mean+s.e.; CNet cpm+s.e. (x 103) of CTLL;
dCompared to healthy control using Student's t test.
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Figure 1 Effect of addition of exogenous IL-2CM on PHA
induced blastogenesis and colony formation by splenic
lymphocytes from HD patients and controls. 100P1 IL-2CM
contains IL-2 equivalent to - 2U standard IL-2 (Electro-
Nucleonics, USA). *P<O.01; **P<O.001.
(Mukhopadhyaya et al., 1987). On the other hand, activated
T-cells from HD blood did not show improvement in colony
formation upon addition of IL-2CM, while the colony
formation of normal blood lymphocytes improved
significantly. In comparison to this, HD spleen lymphocytes
showed responses like normal blood and normal spleen
lymphocytes upon supplementation with IL-2CM. There was
an improvement in colony formation, while there was no
change in blastogenic potential (Figure 1).
Thus it appears that in all assays, spleen lymphocytes from
HD patients behaved more closely to normal lymphocytes in
their T-cell responses. These observations, therefore,
emphasize the apparently normal functional status of HD
spleen lymphocytes, by contrast with the peripheral blood
compartment which shows moderate to gross impairment in
the steps involved in T-cell proliferation. These studies also
indicate that it is possible to delineate the two post-
activation events, viz. blastogenic and clonal expansion. It
has been suggested earlier that cells undergoing mitogen-
induced blast transformation and those undergoing colony
formation may not belong to the same cellular pool (Triebel
et al., 1981), and that the colony forming precursors
constitute a small selective pool of cells (Dao et al., 1978).
Also, different subsets of colony progenitors among the T-
cell population are known to exist (Farcet et al., 1984). It is
tempting to suggest that in HD peripheral blood, there could
be a partial selective depletion of these precursors whereas
this abnormality may not exist in spleen.
Similar observations of low IL-2 production and/or IL-2R
expression in HD blood lymphocytes have been reported by
us and others (Zamkoff et al., 1985; Soullillou et al., 1985;
Joshi et al., 1987). However, comparatively normal IL-2
mediated splenic lymphocyte functions, irrespective of the
invasion of the tissue by malignant cells, has not been
previously reported. The lower IL-2 yield by splenic
lymphocytes is probably due to a comparatively lower
number of potential IL-2 generating T4 cells per se in splenic
tissues (Reinecke & Pabst, 1983). The presence of large
numbers of Tac+ cells in resting splenic lymphocytes
probably indicates that an IL-2 mediated immune activation
of T-cells may actually occur in local lymphoid organs.
Miyawaki et al. (1984) demonstrated histochemically, Tac+
cells in lymphomas. It will be interesting to see if they are
more abundant in the vicinity of RS cells in HD.
In conclusion, our data support the possibility that T-cell
dysfunction in HD is perhaps confined to the peripheral
blood compartment, while spleen lymphocytes show a
normal functional pattern.
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